Clinical and pharmacological group: & nbsp

Nootropics

Included in the formulation
  • Alphofolin-Lekpharm
    solution w / m in / in 
    LEKFARM, SOOO     Republic of Belarus
  • Glacer
    solution w / m in / in 
    EKOFARMPLUS, CJSC     Russia
  • Gliatilin
    solution w / m d / infusion 
    Italfarmaco SpA     Italy
  • Gliatilin
    capsulessolution inwards w / m in / in 
    Italfarmaco SpA     Italy
  • Gliatilin
    capsulessolution inwards w / m in / in 
    Italfarmaco SpA     Italy
  • Gliatilin
    solution inwards 
    Italfarmaco SpA     Italy
  • Delecite
    solution w / m d / infusion 
    ITF, LLC     Russia
  • Delecite
    capsules inwards 
    ITF, LLC     Russia
  • Noochlin Rompharm
    solution w / m in / in 
  • Choline alfoscerate
    solution w / m in / in 
    Company DEKO, LLC     Russia
  • Choline alfoscerate
    solution w / m in / in 
    PharmIntelekt, OOO     Russia
  • Choline alfoscerate
    solution w / m in / in 
  • Choline alfoscerate
    solution w / m in / in 
    ATOLL, LLC     Russia
  • Choline alfoscerate
    solution w / m d / infusion 
    BIOSINTEZ, PAO     Russia
  • Choline alfoscerate
    solution inwards 
  • Holilitil
    solution w / m in / in 
    Company DEKO, LLC     Russia
  • Holilitil
    capsules inwards 
    ARTLIFE, LLC     Russia
  • Cerepro®
    solution w / m in / in 
    VEROPHARM SA     Russia
  • Cerepro
    capsulessolution inwards w / m in / in 
    VEROPHARM SA     Russia
  • Cereton®
    solution w / m in / in 
  • Cereton
    capsules inwards 
  • Cereton®
    solution inwards 
  • Included in the list (Order of the Government of the Russian Federation No. 2782-r of 30.12.2014):

    ONLS

    VED

    АТХ:

    N.07.A.X.02   Choline alfoscerate

    Pharmacodynamics:

    It is a substrate for the synthesis of phosphatidylcholine neuronal membranes and acetylcholine. It interacts mainly with the cholinergic receptors of the central nervous system. It improves cerebral blood flow, improves receptor function and plasticity of neuronal membranes, stimulates the reticular formation and metabolism in the central nervous system.

    It improves concentration of attention, stimulates mental activity, improves cognitive function, eliminates apathy and emotional instability. Promotes regress of neurological symptoms after traumatic brain injuries.

    Pharmacokinetics:

    After oral administration, up to 88% is absorbed in the gastrointestinal tract. Penetrates through the blood-brain barrier and accumulates in the brain - up to 45% of the amount in the blood plasma.

    It is biotransformed to glycerophosphate and choline, which have pharmacological activity.

    Elimination in the form of carbon dioxide light (up to 85%), the remaining 15% are excreted with feces and kidneys.

    Indications:

    It is used for the treatment of chronic cerebrovascular insufficiency, Alzheimer's disease and dementia, Huntington's chorea, senile pseudomelanchia. Used for craniocerebral trauma in an acute period, as well as in the early and late recovery period after an ischemic stroke.

    V.F00-F09.F00 *   Dementia in Alzheimer's disease (G30 .- +)

    V.F00-F09.F01   Vascular dementia

    V.F00-F09.F07   Personality and behavioral disorders due to illness, damage or dysfunction of the brain

    V.F00-F09.F07.2   Postcontasia syndrome

    VI.G20-G26.G25.5   Other types of chorea

    IX.I60-I69.I63   Cerebral infarction

    XIX.S00-S09.S06   Intracranial injury

    Contraindications:

    Acute phase of hemorrhagic stroke, individual intolerance, children under 18 years of age.

    Carefully:

    Hypersensitivity.

    Pregnancy and lactation:

    Recommendations for FDA - Category C. Contraindicated in pregnancy and lactation.

    Dosing and Administration:

    Intramuscularly or intravenously, slowly 1 g per day in the morning in acute conditions, up to 15-20 days. Then on 800 mg from the morning and on 400 mg in the afternoon during 6 months.

    Inside, 400 mg 2-3 times daily before meals.

    The highest daily dose: 1200 mg.

    The highest single dose: 400 mg for oral administration and 800 mg for parenteral administration.

    Side effects:

    Nausea.

    Allergic reactions.

    Overdose:

    Cases of overdose are not described.

    Treatment is symptomatic.

    Interaction:

    Clinically significant interactions are not described.

    Special instructions:

    When there is nausea, it is recommended to lower the dose.

    Instructions
    Up